Literature DB >> 17906085

Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults.

B Balbi1, P Pignatti, M Corradi, P Baiardi, L Bianchi, G Brunetti, A Radaeli, G Moscato, A Mutti, A Spanevello, M Malerba.   

Abstract

Bronchoalveolar lavage (BAL), induced sputum and exhaled breath markers (exhaled nitric oxide and exhaled breath condensate) can each provide biological insights into the pathogenesis of respiratory disorders. Some of their biomarkers are also employed in the clinical management of patients with various respiratory diseases. In the clinical context, however, defining normal values and cut-off points is crucial. The aim of the present review is to investigate to what extent the issue of defining normal values in healthy adults has been pursued for the biomarkers with clinical value. The current authors reviewed data from literature that specifically addressed the issue of normal values from healthy adults for the four methodologies. Most studies have been performed for BAL (n = 9), sputum (n = 3) and nitric oxide (n = 3). There are no published studies for breath condensate, none of whose markers yet has clinical value. In healthy adult nonsmokers the cut-off points (mean+2sd) for biomarkers with clinical value were as follows. BAL: 16.7% lymphocytes, 2.3% neutrophils and 1.9% eosinophils; sputum: 7.7 x 10(6).mL(-1) total cell count and 2.2% eosinophils; nitric oxide: 20.2 ppb. The methodologies differ concerning the quantity and characteristics of available reference data. Studies focusing on obtaining reference values from healthy individuals are still required, more evidently for the new, noninvasive methodologies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17906085     DOI: 10.1183/09031936.00112306

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  27 in total

1.  Flow cytometry of sputum: assessing inflammation and immune response elements in the bronchial airways.

Authors:  John C Lay; David B Peden; Neil E Alexis
Journal:  Inhal Toxicol       Date:  2011-06       Impact factor: 2.724

2.  Bronchoalveolar lavage cell pattern from healthy human lung.

Authors:  M Heron; J C Grutters; K M ten Dam-Molenkamp; D Hijdra; A van Heugten-Roeling; A M E Claessen; H J T Ruven; J M M van den Bosch; H van Velzen-Blad
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

3.  Simplified detection of eosinophils in induced sputum.

Authors:  Elizabeth Fireman; Brenda Toledano; Nina Buchner; Moshe Stark; Yehuda Schwarz
Journal:  Inflamm Res       Date:  2011-04-05       Impact factor: 4.575

Review 4.  Exhaled breath condensate collection in the mechanically ventilated patient.

Authors:  Stewart R Carter; Christopher S Davis; Elizabeth J Kovacs
Journal:  Respir Med       Date:  2012-03-06       Impact factor: 3.415

Review 5.  Exhaled Breath Condensate (EBC): Is It a Viable Source of Biomarkers for Lung Diseases?

Authors:  Stefanos Patsiris; Themis Exarchos; Panayiotis Vlamos
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

6.  Biomarkers in exhaled breath condensate: a review of collection, processing and analysis.

Authors:  N M Grob; M Aytekin; R A Dweik
Journal:  J Breath Res       Date:  2008-09-08       Impact factor: 3.262

7.  Predictive modeling and inflammatory biomarkers in rats with lung contusion and gastric aspiration.

Authors:  Krishnan Raghavendran; Bruce A Davidson; Alan D Hutson; Jadwiga D Helinski; Scott R Nodzo; Robert H Notter; Paul R Knight
Journal:  J Trauma       Date:  2009-12

Review 8.  Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease.

Authors:  Joanna L Richens; Richard A Urbanowicz; Elizabeth A M Lunt; Rebecca Metcalf; Jonathan Corne; Lucy Fairclough; Paul O'Shea
Journal:  Respir Res       Date:  2009-04-22

9.  Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects.

Authors:  Annette T Hastie; Wendy C Moore; Huashi Li; Brian M Rector; Victor E Ortega; Rodolfo M Pascual; Stephen P Peters; Deborah A Meyers; Eugene R Bleecker
Journal:  J Allergy Clin Immunol       Date:  2013-05-21       Impact factor: 10.793

10.  Exhaled and Nasal Nitric Oxide - Impact for Allergic Rhinitis.

Authors:  M Antosova; A Bencova; D Mokra; J Plevkova; L Pepucha; T Buday
Journal:  Physiol Res       Date:  2020-03-27       Impact factor: 1.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.